skip to the content

Nutley Newsroom

Our aim is to provide clear, accurate and timely information about Nutley R&D and other business activities.

As announced in June 2012, as part of an effort to streamline global research and development, reseach projects in Nutley, will be transferred to locations in Europe and the Nutley site will cease business operations at the end of 2013. Roche Pharma will continue to have a presence on the US East Coast with a Pharmaceuticals Translational Clinical Research Center (new location to be selected).

Nutley Press Releases

Tue April 30, 2013

Roche highlights commitment to research in cancer and viral immunology with second Roche–Nature Medicine Immunology Symposium

Mon April 08, 2013

Roche and Isis Pharmaceuticals form alliance for Huntington’s disease

Wed April 03, 2013

Master plan architect recommended for Roche Nutley, NJ site
Perkins Eastman Architects to develop plan for repurposing of 119-acre Roche site

Wed February 27, 2013

Roche research sheds light on improving neurological deficits in mouse model of Down syndrome
Results could have implications for individuals with Down syndrome

Thu January 10, 2013

Roche Scientists uncover unexpected enzyme activity in HCV RNA polymerase

Discovery could have implications related to nucleoside drug potency and resistance

Wed November 28, 2012

Roche and the Broad Institute Collaborate to Identify Novel Uses for Advanced Compounds